NCT03652428 2026-03-02
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
University of Maryland, Baltimore
Phase 1/2 Recruiting
University of Maryland, Baltimore
Institute of Oncology Ljubljana
RenovoRx
University of Saskatchewan
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd